Bromotrimethylsilane → HCID 25235408, compound

HRID 1513280Notes

Reaction equation

HRID 1513280 reaction equation
C([O:3][P:4]([CH2:9]/[CH:10]=[CH:11]/[C:12]1[CH:17]=[C:16]([CH3:18])[C:15]([C:19]2[NH:23][C:22]3[CH:24]=[C:25]([C:28]4[O:29][C:30]([C:33]5[CH:38]=[CH:37][C:36]([Cl:39])=[CH:35][CH:34]=5)=[N:31][N:32]=4)[CH:26]=[CH:27][C:21]=3[N:20]=2)=[C:14]([CH3:40])[CH:13]=1)(=[O:8])[O:5]CC)C.C[Si](Br)(C)C>C(Cl)Cl>[Cl:39][C:36]1[CH:37]=[CH:38][C:33]([C:30]2[O:29][C:28]([C:25]3[CH:26]=[CH:27][C:21]4[N:20]=[C:19]([C:15]5[C:16]([CH3:18])=[CH:17][C:12]([CH2:11][CH2:10][CH2:9][P:4](=[O:3])([OH:8])[OH:5])=[CH:13][C:14]=5[CH3:40])[NH:23][C:22]=4[CH:24]=3)=[N:32][N:31]=2)=[CH:34][CH:35]=1

Participants

4

Procedure

To a solution of [(E)-3-(4-{6-[5-(4-chlorophenyl)-[1,3,4]oxadiazol-2-yl]-1H-benzoimidazol-2-yl}-3,5-dimethylphenyl)-allyl]-phosphonic acid diethyl ester (1.44 g, 2.5 mmol) in CH2Cl2 (15 mL) was added trimethylsilylbromide (1.62 mL, 12.5 mmol) and the mixture was stirred at RT for 18 h. The solvent was removed under reduced pressure and the residue was purified by reverse phase HPLC using a gradient of 0-80% MeCN/water containing 0.7% NH4OH to give the title compound. MS: m/z 523.1 (M+1). H1-NMR (DMSO-d6): δ ppm 8.46 (s, 0.6H), 8.19 (d, J=8.59 Hz, 2H), 8.0 (d, J=8.21 Hz, 1H), 7.88 (s, broad, 0.4H), 7.72 (d, J=8.59 Hz, 2H), 7.05 (s, 2H), 2.64 (t, 2H), 2.11 (s, 6H), 1.78 (m, 2H), 1.41 (m, 2H).

Workup

  1. customThe solvent was removed under reduced pressure
  2. customthe residue was purified by reverse phase HPLC

Sources & evidence

ORD record
ord-4ceff2fc9d4d4290bc922133e9aa1538
Source dataset
uspto-grants-2012_07
Patent number
US08217065B2

Reaction notes

Loading…